Enable job alerts via email!
Boost your interview chances
Create a job specific, tailored resume for higher success rate.
An established industry player is seeking an experienced Medical Value & Access Liaison to join their innovative Medical Affairs team. This role involves engaging with key national and regional decision makers, providing crucial clinical and economic insights, and fostering relationships within the managed care landscape. The ideal candidate will have a strong background in oncology and a proven track record in the pharmaceutical or biotech sectors. This position offers the flexibility of remote work while contributing to the mission of improving patient outcomes through pioneering therapies. If you thrive in dynamic environments and are passionate about making a difference, this opportunity is for you.
Arvinas is a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. Arvinas uses its proprietary PROTAC Discovery Engine platform to engineer proteolysis targeting chimeras, or PROTAC targeted protein degraders, that are designed to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins.
In addition to its robust preclinical pipeline of PROTAC protein degraders against validated and “undruggable” targets, the company has three investigational clinical-stage programs currently enrolling: vepdegestrant for the treatment of patients with locally advanced or metastatic ER+/HER2- breast cancer; ARV-102 for the treatment of patients with neurodegenerative disorders, and ARV-393 for the treatment of patients with relapsed/refractory non-Hodgkin Lymphoma and potentially other lymphomas.
In April 2024, Arvinas entered into a transaction with Novartis, including a global license agreement for the development and commercialization of the clinical stage PROTAC androgen receptor protein degrader ARV-766 for the treatment of prostate cancer. The transaction closed in May 2024.
#TeamArvinas is made up of approximately 450 passionate and curious employees, whose diverse thoughts and perspectives are highly valued. Arvinas employees embrace the freedom to pursue innovation, think creatively, and give back. They are driven by the company’s values and mission – to improve the lives of patients with serious diseases by pioneering therapies created with our revolutionary PROTAC protein degradation platform.
Arvinas has an exciting opportunity for an experienced professional to join our Medical Affairs team. The Medical Value & Access Liaison (MVAL) is a field-based scientific expert who applies clinical, health economic, managed care, and health policy expertise to engage in peer-to-peer scientific and clinical value discussions with top key national and relevant regional decision makers. This position will cover the Western United States.
This position reports to the Director & Team Lead, Medical Value & Access Lead, and can be based remotely from a location within the U.S.
Key responsibilities of this role include, but are not limited to:
Qualifications
Education
Arvinas is proud to offer a competitive package of base and incentive compensation as well as a comprehensive benefits program designed to support the health, wellness, and financial security of our employees and their families. Benefits include group medical, vision and dental coverage, group and supplemental life insurance, and much more. To learn more about Arvinas, please visit www.arvinas.com
Arvinas is an Equal Opportunity Employer